Molecular mechanisms of the action of Arctigenin in cancer

Yinghua He1, Qiaomei Fan1, Tiantian Cai1

  • 1Department of Pharmacy, The First Affiliated Hospital of Zhejiang Chinese Medicine University, Xiasha District, Hangzhou, Zhejiang 310018, China; Department of Pharmacy, Zhejiang International Exchange Center of Clinical Traditional Chinese Medicine, Xiasha District, Hangzhou, Zhejiang 310018, China; Department of Pharmacy, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Xiasha District, Hangzhou, Zhejiang 310018, China.

Insights

Arctigenin (ATG), a natural compound from Arctium lappa, shows significant anticancer activity by inhibiting various cancer cell growth. This review analyzes its molecular pathways and drug interactions for potential cancer therapies.

Area of Science:

  • Natural product chemistry
  • Molecular oncology
  • Pharmacology

Background:

  • Natural compounds offer potential for cancer treatment.
  • Arctigenin (ATG) from Arctium lappa exhibits anticancer properties.
  • Understanding ATG's molecular mechanisms is crucial for therapeutic development.

Purpose of the Study:

  • To summarize and analyze the molecular pathways of arctigenin's anticancer effects.
  • To highlight the interactions of arctigenin with other drugs.

Main Methods:

  • Literature review and analysis of existing studies on arctigenin.
  • Examination of molecular pathways involved in arctigenin's biological activities.
  • Investigation of drug-drug interactions involving arctigenin.

Main Results:

  • Arctigenin inhibits the growth of diverse cancer cells (stomach, lung, liver, colon, leukocytes).
  • ATG modulates key intracellular activities including antioxidative, anti-inflammatory, and anticancer functions.
  • The paper provides an overview of arctigenin's molecular targets and signaling pathways.

Conclusions:

  • Arctigenin demonstrates broad-spectrum anticancer potential through various molecular mechanisms.
  • Further research into arctigenin's pathways and drug interactions can lead to novel cancer therapies.
  • Natural compounds like arctigenin are promising candidates for cancer treatment development.

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.9K
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
3.3K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K